These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28095579)

  • 1. Development and Clinical Assessment of a Comprehensive Product for Pigmentation Control in Multiple Ethnic Populations.
    Makino ET; Kadoya K; Sigler ML; Hino PD; Mehta RC
    J Drugs Dermatol; 2016 Dec; 15(12):1562-1570. PubMed ID: 28095579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
    Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
    J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone.
    Dahl A; Yatskayer M; Raab S; Oresajo C
    J Drugs Dermatol; 2013 Jan; 12(1):52-8. PubMed ID: 23377328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro and In Vivo Efficacy and Tolerability of a Non-Hydroquinone, Multi-Action Skin Tone Correcting Cream.
    Grimes PE; McDaniel DH; Wortzman M; Nelson D
    J Drugs Dermatol; 2019 Jul; 18(7):642-648. PubMed ID: 31329402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
    Kaufman BP; Alexis AF
    J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging.
    Fabi SG; Goldman MP
    J Drugs Dermatol; 2013 Mar; 12(3):S32-7. PubMed ID: 23545931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
    Bruce S
    J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of In-Office Chemical Peels With a Topical Comprehensive Pigmentation Control Product in Skin of Color Subjects With Facial Hyperpigmentation.
    Downie J; Schneider K; Goberdhan L; Makino ET; Mehta RC
    J Drugs Dermatol; 2017 Apr; 16(4):301-306. PubMed ID: 28403262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized, Investigator-Blinded Comparison of Two Topical Regimens in Fitzpatrick Skin Types III-VI With Moderate to Severe Facial Hyperpigmentation.
    Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Wu DC; Goldman MP
    J Drugs Dermatol; 2017 Nov; 16(11):1127-1132. PubMed ID: 29141061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment of skin lightening cosmetics containing hydroquinone.
    Matsumoto M; Todo H; Akiyama T; Hirata-Koizumi M; Sugibayashi K; Ikarashi Y; Ono A; Hirose A; Yokoyama K
    Regul Toxicol Pharmacol; 2016 Nov; 81():128-135. PubMed ID: 27521610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Anti-Melanogenesis Properties of Polydeoxyribonucleotide, a Popular Wound Healing Booster.
    Noh TK; Chung BY; Kim SY; Lee MH; Kim MJ; Youn CS; Lee MW; Chang SE
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic skin whitening/lightening agents: what is the evidence?
    Malathi M; Thappa DM
    Indian J Dermatol Venereol Leprol; 2013; 79(6):842-6. PubMed ID: 24177629
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of melanin content by Punicalagins in the super fruit pomegranate (Punica granatum).
    Rana J; Diwakar G; Saito L; Scholten JD; Mulder T
    J Cosmet Sci; 2013; 64(6):445-53. PubMed ID: 24397882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone.
    Draelos ZD
    J Am Acad Dermatol; 2015 Jan; 72(1):105-7. PubMed ID: 25440437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of new depigmenting compounds and their efficacy to treat hyperpigmentation: Evidence from in vitro study.
    Lajis AFB; Ariff AB
    J Cosmet Dermatol; 2019 Jun; 18(3):703-727. PubMed ID: 30866156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of sake extract as a new anti-melanogenic ingredient by in vitro and clinical trials.
    Hwang JA; Goh MJ; Kim EJ; Lee MR; Park NH; Na YJ; Cho JC; Lee HK
    Nat Prod Commun; 2013 Nov; 8(11):1605-8. PubMed ID: 24427952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies.
    Sonthalia S; Daulatabad D; Sarkar R
    Indian J Dermatol Venereol Leprol; 2016; 82(3):262-72. PubMed ID: 27088927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Topical treatment of hyperpigmentation disorders].
    Rendon M; Horwitz S
    Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S102-7. PubMed ID: 23260517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytidine decreases melanin content in a reconstituted three-dimensional human epidermal model.
    Baswan SM; Yim S; Leverett J; Scholten J; Pawelek J
    Arch Dermatol Res; 2019 Apr; 311(3):249-250. PubMed ID: 30788567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.